A recent bioinformatic study using the GEO database showed that angiotensin-converting enzyme 2 (ACE2) is elevated in uterine corpus endometrial carcinoma and renal papillary cell carcinoma. This evidence concerns the gene ACE2 and uterine corpus endometrial carcinoma.